Lixisenatide shows benefits comparable to exenatide in diabetes

06/6/2013 | PhysiciansBriefing.com

Once-daily lixisenatide was as effective as twice-daily exenatide in improving A1C and fasting plasma glucose levels in adult type 2 diabetes patients who showed poor response to metformin, according to a study in Diabetes Care. Researchers also noted lower incidence of symptomatic hypoglycemia and gastrointestinal events among lixisenatide-treated patients than in those who took exenatide. However, the lixisenatide group had less weight loss compared with the exenatide group, researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA